Tempus AI Falls 15% on Weak Q4 but EBITDA View Strong: Buy the Dip?Zacks Investment Research • 02/26/25
Tempus to Participate in the Morgan Stanley Technology, Media and Telecom ConferenceBusiness Wire • 02/18/25
Tempus Announces Collaboration with IFLI Aimed at Supporting Development of Targeted Therapies for Follicular LymphomaBusiness Wire • 02/13/25
Think It's Too Late to Buy Tempus AI Stock? Here's the Biggest Reason Why There's Still Time.The Motley Fool • 02/13/25